Sign In
Buy MBII
$0.798
+0 (+0%)
At Close: Nov 04, 2022
Karla Medina-Ortega Joins Certis USA as Regional Field Development Manager
12:00am, Tuesday, 26'th May 2020
Certis USA, the leader in biopesticides, today announced its hiring of Dr. Karla Medina-Ortega as Field Development Manager for Southern USA.
Global Bio-herbicides Market Analysis and Outlook 2020-2028 - ResearchAndMarkets.com
12:00am, Thursday, 21'st May 2020
The
MBII: Marrone now covers two of the largest areas of organic cannabis cultivation in N. America.
09:25am, Friday, 15'th May 2020
By Ian Gilson, PhD, CFA NASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio Innovations (NASDAQ:MBII) has announced that it has received the first approval of the use of REGALIA MAXX biofungici
Aegis Capital Maintains Buy on Marrone Bio Innovations, Lowers Price Target to $1.4
05:17pm, Thursday, 14'th May 2020Marrone Bio Innovations' REGALIA MAXX Receives First Approval For Use On Cannabis And Hemp In Canada
12:37pm, Thursday, 14'th May 2020Marrone Bio Innovations’ REGALIA® MAXX Receives First Approval for Use on Cannabis and Hemp in Canada
12:31pm, Thursday, 14'th May 2020
Marrone Bio Innovations, Inc. (MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that REGALIA® MAXX biofungicide received the first approva
Tracking Kahn Brothers Portfolio - Q1 2020 Update
10:02am, Thursday, 14'th May 2020
Kahn Brothers’ 13F portfolio value decreased from $825M to $547M this quarter. The New York Times position was almost sold out during the quarter. The portfolio
Marrone Bio Innovations' REGALIA® MAXX Receives First Approval for Use on Cannabis and Hemp ...
12:00am, Thursday, 14'th May 2020Worldwide Biopesticide Competitive Analysis and Leadership Study 2018 - ResearchAndMarkets.com
12:00am, Wednesday, 13'th May 2020
The
By Ian Gilson, PhD, CFA NASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio Innovations (NASDAQ:MBII) reported record revenue and a further increase in gross margins in the first quarter of 202
Marrone Bio Innovations, Inc. (MBII) Pam Marrone on Q1 2020 Results - Earnings Call Transcript
12:15am, Tuesday, 12'th May 2020
Marrone Bio Innovations, Inc. (NASDAQ:MBII) Q1 2020 Earnings Conference Call May 11, 2020, 04:30 PM ET Company Participants Linda Moore - General Counsel Jim Bo
Marrone Bio Innovations Q1 EPS $(0.050) Misses $(0.030) Estimate, Sales $9.650M Miss $10.110M Estimate
08:29pm, Monday, 11'th May 2020Marrone Bio Innovations, Inc. Reports First Quarter 2020 Financial Results
08:05pm, Monday, 11'th May 2020
Record Revenues; Seventh Consecutive Quarter of Year Over Year Revenue Growth Realized in Challenging Environment for Agricultural Production Record Gross Margins Mark Sixth.
MBIA Inc. Reports First Quarter 2020 Financial Results
12:00am, Monday, 11'th May 2020
MBIA Inc. (NYSE:MBI) today posted its first quarter 2020 financial results on its website at https://investor.mbia.com/investor-relations/financial-in
